Recently, we showed that leukotrienes (LTs) regulate ovarian cell function in vitro. The aim of this study was to examine the role of LTs in corpus luteum (CL) function during both the estrous cycle and early pregnancy in vivo. mRNA expression of LT receptors (BLT for LTB 4 and CYSLT for LTC 4 ), and 5-lipoxygenase (5-LO) in CL tissue and their localization in the ovary were studied during the estrous cycle and early pregnancy. Moreover, concentrations of LTs (LTB 4 and C 4 ) in the CL tissue and blood were measured. 5-LO and BLT mRNA expression increased on days 16-18 of the cycle, whereas CYSLT mRNA expression increased on days 16-18 of the pregnancy. The level of LTB 4 was evaluated during pregnancy compared with the level of LTC 4 , which increased during CL regression. LT antagonists influenced the duration of the estrous cycle: the LTC 4 antagonist (azelastine) prolonged the luteal phase, whereas the LTB 4 antagonist (dapsone) caused earlier luteolysis in vivo. Dapsone decreased progesterone (P 4 ) secretion and azelastine increased P 4 secretion during the estrous cycle. In summary, LT action in the bovine reproductive tract is dependent on LT type: LTB 4 is luteotropic during the estrous cycle and supports early pregnancy, whereas LTC 4 is luteolytic, regarded as undesirable in early pregnancy. LTs are produced/secreted in the CL tissue, influence prostaglandin function, and serve as important factors during the estrous cycle and early pregnancy in cattle.
Introduction
The corpus luteum (CL) is the principal source of progesterone (P 4 ) in mammals. P 4 supports the secretory functions of the endometrium, which sustain early embryonic development, implantation, and placentation (Niswender et al. 2000) . In cows, the main signal for pregnancy recognition and CL maintenance is interferon t (IFNT; Thatcher et al. 2001 , Spencer et al. 2007 , Bazer et al. 2008 . Nevertheless, the bovine conceptus produces numerous signals during early pregnancy including steroids, prostaglandins (PGs), and other proteins (Lewis et al. 1982 , Eley et al. 1983 , Thatcher et al. 1984 . Uterine and ovarian PGs are considered to be important factors for regulating reproductive events such as ovulation, luteolysis, embryo implantation, and maintaining pregnancy (Weems et al. 2006) . Generally, PGE 2 acts in luteotropic and luteoprotective ways, which leads to lengthening of the lifespan of the CL and P 4 production (Weems et al. 1997 , Kotwica et al. 2003 , whereas PGF 2a is the main luteolytic agent in ruminants (McCracken et al. 1999) . Thus, in signaling from the conceptus to the maternal system for maternal recognition of pregnancy, the correct contact between IFNT and all ovarian and uterine factors, such as P 4 and PGs, plays a pivotal role (Arosh et al. 2004 , Weems et al. 2006 . In this study, we examine the action of leukotrienes (LTs) as another potential trigger of reproductive processes in cattle.
LTs are synthesized by 5-lipoxygenase (5-LO) and are commonly known as potential inflammatory factors that cause edema in respiratory tract diseases, but they also have roles in reproduction and may enhance the action of PGs (Samuelsson 2000) . Receptors for LTs are classified into two separate groups with respect to structure and cell location: BLT for LTB 4 and CYSLT for cysteinyl LTs (LTC 4 , LTD 4 , and LTE 4 ; Izumi et al. 2002) . In humans, there are two isoforms of receptor for LTB 4 (LTB4R and LTB4R2, also known as BLT1 and BLT2; Tager & Luster 2003) and at least two receptors for cysteinyl LTs (CYSLTR1 and CYSLTR2; Jones & Rodger 1999) , whereas there are no data about the protein expression/localization of LT receptors in the bovine reproductive tract. LTs play a role in the bovine reproductive tract: intraluteal infusion of PGF 2a by a microdialysis system on day 12 of the estrous cycle was shown to increase the levels of both LTB 4 and C 4 in CL perfusate (Blair et al. 1997) . The secretory functions of bovine CL cells were shown to be regulated not only by PGs but also by LTs (Milvae et al. 1986 , Korzekwa et al. 2010a , 2010b . We recently showed that mRNA for 5-LO and LT receptors is expressed in ovarian cell types, including steroidogenic and endothelial CL cells and granulosa cells (Korzekwa et al. 2010b) . LTs are found to be auto/paracrine factors modulating the secretory functions of ovarian cells depending on the stage of the cycle and type of LT. LTB 4 seems to play a luteotropic role in the CL, stimulating P 4 and PGE 2 secretions, whereas LTC 4 stimulates the secretion of luteolytic PGF 2a and may enhance the luteolytic cascade within the bovine CL steroidogenic cells (Korzekwa et al. 2010a) . These in vitro results need to be supported by in vivo studies to help us understand the complete effects of LT action on the bovine reproductive tract during the estrous cycle. Moreover, there is a lack of knowledge about the role of LTs in early pregnancy.
The main goal of this study was to determine and compare the actions of endogenous LTs at the end of luteal phase of the estrous cycle and during early pregnancy in cattle. We monitored the concentrations of selected LTs, B 4 and C 4 , in the plasma and CL tissue and we evaluated their production and expression in the CL tissue during the estrous cycle compared with early pregnancy. Furthermore, we examined the influence of endogenous LTs on the CL lifespan and function, as well as secretory function in the reproductive tract on day 16 of cycle/pregnancy by measuring P 4 and PG (PGE 2 and PGFM) concentrations in the blood samples after infusion of selective antagonists of LTB 4 and C 4 into the aorta abdominalis.
Results
Experiment 1: LT mRNA expression and production in the bovine CL tissue and its localization in the ovary during the estrous cycle and in early pregnancy Figure 1 shows mRNA expression for LTRs (BLT and CYSLT) and 5-LO in the CL tissue during the estrous cycle and early pregnancy. BLT mRNA expression was upregulated on days 16-18 of pregnancy (P!0.05), whereas CYSLT mRNA expression was higher on days 8-10 and 16-18 of the estrous cycle (P!0.05). 5-LO mRNA expression was upregulated on days 16-18 of pregnancy (P!0.05).
Light microscopic observations for immunohistochemical staining of BLT and CYSLT and 5-LO localization in ovarian tissue on days 8-10 of the estrous cycle as a representative period are shown in Fig. 2 . BLT and CYSLT and 5-LO were not only present in theca and stromal cells and in the area of preantral follicles but also in epithelial cells, smooth muscle cells of ovarian aortas, and in steroidogenic luteal cells of the CL. LTB 4 concentration remained unchanged throughout the cycle (days 2-4, 8-10, and 16-18, PO0.05; Fig. 3 ) but increased on days 8-10 and 16-18 of pregnancy (P!0.05). LTC 4 concentration was higher on days 16-18 of the cycle and lower on days 8-10 and 16-18 of pregnancy (P!0.05).
Experiment 2: LTB 4 and C 4 concentrations in the blood during the estrous cycle and early pregnancy Figure 4 shows LTB 4 and C 4 concentrations during the estrous cycle and early pregnancy in blood collected from jugular vein on days 0, 2, 8, 10, 15, 16, 17, and 21 . During the cycle, the level of LTC 4 increased between days 15 and 17 of the estrous cycle (P!0.05), whereas the level of LTB 4 during the cycle remained unchanged (PO0.05). During pregnancy, the level of LTC 4 was stable (PO0.05), whereas the level of LTB 4 increased from day 8 (P!0.05).
Experiment 3: effects of LT antagonists on P 4 and PGs output and CL lifespan in vivo Preliminary study: establishing the effective dose of LTB 4 and LTC 4 antagonists P 4 concentrations in blood plasma of control and experimental cows during the 24 h following LT infusion are shown in Fig. 5a and b. Azelastine at doses of 10 and 100 mg did not influence P 4 concentration in blood plasma in comparison with the control cows ( Fig. 5a ; PO0.05). Azelastine at a dose of 250 mg elevated secretion of P 4 in the blood plasma compared with the control cows between 10 and 18 h following infusion (P!0.05; Fig. 5a ). Although dapsone at a dose of 10 mg temporarily increased the level of P 4 at 2, 3, 8, and 18 h of the experiment (P!0.05; Fig. 5b) , a dose of 100 mg did not influence secretion of P 4 in the blood plasma compared with the control cows (PO0.05; Fig. 5b ). Dapsone at a dose of 250 mg inhibited P 4 secretion from 1 h after infusion (P!0.05; Fig. 5b ). Additionally, in order to establish the effective dose of LT antagonists, the PG levels were measured (data not shown because no changes were observed following doses of 10 and 100 mg for both LT antagonists).
Effects of LT antagonists on P 4 and PG secretion, and on the lifespan of the CL during the estrous cycle and early pregnancy
The effects of azelastine and dapsone infusion (250 mg doses, as selected in the preliminary study) on the lifespan of the CL during the a) estrous cycle and b) early pregnancy are shown in Fig. 6 . Azelastine at a dose of 250 mg was capable of prolonging the luteal phase of the estrous cycle for more than 30 days by increasing the lifespan of the CL (P!0.05; Fig. 6a ). On the contrary, dapsone at a dose of 250 mg shortened the length of the estrous cycle to 17G0.8 days compared with saline-treated cows (day 21G0.9, P!0.05; Fig. 6a ). Azelastine did not influence CL function during early pregnancy (PO0.05; Fig. 6b) . Dapsone decreased the level of P 4 from day 21 to day 30-32 (from 10.25G1.5 to 2.5G1.1 ng/ml) of pregnancy (PO0.05; Fig. 6b and the absence of pregnancy was confirmed (by ultrasonography, USG) on day 36. Figure 7 shows P 4 , PGE 2 , and PGFM concentrations in blood plasma of control and experimental cows after infusion of azelastine and dapsone (250 mg) on day 16 of the estrous cycle ( Fig. 7a -c) and pregnancy ( Fig. 7d-f ). During the estrous cycle, azelastine stimulated P 4 output between 10 and 18 h after infusion (P!0.05; Fig. 7a ). Dapsone inhibited P 4 output from 1 h after infusion (P!0.05; Fig. 7a ). During pregnancy, neither antagonist influenced secreted P 4 in blood plasma (PO0.05; Fig. 7d ).
During the estrous cycle, azelastine at a dose of 250 mg stimulated PGE 2 output at 0.5 h after infusion and from 10 h onward (P!0.05; Fig. 7b ). However, dapsone at a dose of 250 mg did not influence secreted PGE 2 in blood plasma compared with the control cows and PGE 2 output during the first 24 h of experiment in the cycle (PO0.05; Fig. 7b ). During pregnancy, the same LTB 4 antagonist decreased PGE 2 output and secretion at 1 h after infusion and from 4 h onward (P!0.05; Fig. 7e ), whereas azelastine did not alter PGE 2 secretion in blood plasma compared with the control cows and PGE 2 output during the 24 h after infusion ( Fig. 7e ; PO0.05).
Dapsone increased PGFM output in comparison to the control cows during the 24 h following infusion in the estrous cycle (P!0.05; Fig. 7c ). On the other hand, azelastine did not influence PGFM concentration in blood plasma in comparison to the control cows ( Fig. 7c ; PO0.05). In pregnant cows, dapsone increased PGFM concentration in comparison to the control cows during the 24 h of the experiment (P!0.05; Fig. 7f ), whereas PGFM output was not affected by azelastine (PO0.05; Fig. 7f ).
Discussion
In the present study, we found that LTs are produced and released in the bovine CL, and they modulate the action of P 4 and PGs in the bovine reproductive tract during the estrous cycle and early pregnancy. Our results revealed that LTs influence the lifespan of the CL during the estrous cycle and early pregnancy depending on the type of LT.
The highest levels of mRNA expression for LTRs and 5-LO in the CL tissue were observed on days 16-18 of both the estrous cycle and early pregnancy. We have previously described a similar pattern of mRNA expression of LTRs and 5-LO and production/secretion of LTs during the cycle in the two main cell populations of the bovine CL: steroidogenic and endothelial cells (Korzekwa et al. 2010a (Korzekwa et al. , 2010b . The highest mRNA expression levels for CYSLT and 5-LO were found on days 14-16 of the cycle in endothelial CL cells, whereas BLT mRNA expression did not differ among cell types, which indicated that endothelial cells have the greatest potential for LT production among ovarian cells and are the main source of LTs in the bovine ovary (Korzekwa et al. 2010a (Korzekwa et al. , 2010b . Nevertheless, Chegini & Rao (1988) showed numerous binding sites for LTC 4 in steroidogenic CL cells between 1.5 and 3 months of pregnancy in cattle. Immunostaining for LTRs and 5-LO showed that they were localized to ovarian vessels and luteal cells of the CL but also in ovarian follicles, which suggests a role for LTs in granulosa cells. www.reproduction-online.org cells (macrophages, monocytes, and leukocytes) infiltrate the ovary and secrete cytokines during the ovulation. Cytokines affect nonsteroidogenic ovarian cells, causing the production/secretion of ovulation mediators, such as metabolites of arachidonic acid, i.e. PGs and LTs. Thus, LTs acting as autocrine or paracrine factors within the bovine CL may be involved not only in processes connected with vasculature, but also with steroidogenic and granulosa cell functions (Korzekwa et al. 2010a (Korzekwa et al. , 2010b . Our data indicate that endogenous LTC 4 inhibits P 4 secretion in the estrous cycle, since azelastine elevated P 4 output. On the contrary, endogenous LTB 4 action enhances P 4 secretion, since dapsone inhibited P 4 output in the estrous cycle. Nevertheless, the role of LTs in early pregnancy seems to be directly connected with PGs because blockade of endogenous LTs by both inhibitors had no effect on changes in P 4 levels during the 24 h after infusion. Although LTs affected the CL lifespan in early pregnancy, the effect of LT action required a longer time after blockade of endogenous LTs by injection of LT antagonists. It is obvious that some factors mediate the action of PGs (Niswender et al. 2000) . LTs of ovarian and/or uterine origin are suggested to be one of these mediators. It would be interesting to know whether LTs directly influence P 4 production/ secretion in the CL, both during the estrous cycle and in the process of embryo implantation during early pregnancy. Nevertheless, based on these in vivo results we are not able to fully understand the molecular interactions between LTs and P 4 . Recent studies have shown that hydroxysteroid (11-b) dehydrogenase 1 (HSD11B1) action is dependent on PGs and P 4 in the period of embryo implantation in cattle (Simmons et al. 2010) . Further studies are needed to determine whether LTs affect the expression of HSD11B1. We showed that the role of LTs in the estrous cycle is strictly type dependent, since LTC 4 inhibited P 4 action, whereas LTB 4 promoted P 4 action in the bovine reproductive tract in vivo. In addition, LT levels measured in plasma during the estrous cycle and early pregnancy confirmed the specification of endogenous LTs dependently on its type in the reproductive tract. The LTB 4 level was elevated during early pregnancy, whereas the LTC 4 level was highest on days 15-17 in plasma and days 16-18 in the CL tissue during the estrous cycle. The levels of both PGs changed after infusion of LTs, both in the estrous cycle and in early pregnancy during the 24 h of the experiment. The LTC 4 antagonist elevated PGE 2 output in the estrous cycle, whereas LTB 4 antagonist elevated PGFM output both in the cycle and pregnancy. An in vitro study carried out on steroidogenic and endothelial bovine CL cells on days 14-16 of the cycle showed that LTs increased secretion of PGE 2 as well as PGF 2a (Korzekwa et al. 2010b) . Moreover, it is likely that the effect of LT secretion on steroidogenesis in the bovine CL is indirect and is mediated/supported by PGs and/or Our results showed that LTB 4 , not LTC 4 , is involved in early pregnancy in cattle because LTB 4 receptor mRNA expression and levels in the CL tissue were higher in pregnancy than in the estrous cycle. In particular, LTB 4 may interact with or mediate PGE 2 and/or IFNT in process of embryo implantation and modulate the action of PGE 2 , which plays a pivotal role in early pregnancy (Weems et al. 1997) . Indeed, a previous study has shown that the highest level of LTA 4 hydrolase gene expression (which converts LTA 4 to LTB 4 and LTC 4 ) was observed in human CL cells at the mid-luteal stage and during pregnancy (Hattori et al. 1998) . A high concentration of LTB 4 in human fetal membranes was shown by Ticconi et al. (1998) and LTB 4 enhanced human placental trophoblast cell function (Sato et al. 2008) .
The data obtained in the current study strengthen the new concept that LTs are auto-and/or paracrine factors regulating reproductive processes in the CL during the estrous cycle and early pregnancy. The mechanisms controlling development, functionality, and regression of the bovine CL involve many factors produced both inside and outside the CL (Niswender et al. 2000) . We have demonstrated the production and secretion of LTs in the CL tissue and their localization in the ovary, and the influence of LTs on PG function during the estrous cycle and early pregnancy. Thus, LTB 4 is luteotropic during the estrous cycle and supports early pregnancy, whereas LTC 4 is luteolytic and its action is not desirable in early pregnancy.
Materials and Methods
All procedures were approved by the Local Animal Care and Use Committee, Olsztyn, Poland (agreement no. 58/2005/N).
A total of 84 healthy Holstein/Polish Black and White (75/25% respectively) cows (3 or 4 lactation) were used for the collection of the ovaries with CL in experiment 1, monitoring of the LT level in experiment 2, and checking the effects of LT antagonists on hormone output and CL lifespan in experiment 3. The animals were eliminated by the owners (Experimental Animal Farm of Polish Academy of Sciences in Baranowo and Agriculture Farm in Cieszymowo, Poland) from the dairy herds because of their lower milk production (years 2007-2009) . The estrus of the cows was synchronized using two 5 mg PGF 2a analog (dinoprost, Dinolytic; UpjohnPharmacia N V S A) i.m. injections with an 11-day interval, as recommended by the vendor. The development of follicles and changes in CL structure during the estrous cycle were monitored by a veterinarian via per rectum USG examination using a Draminski Animalprofi Scanner (Draminski Electronics in Agriculture, Olsztyn, Poland) and confirmed by observing signs of estrus (i.e. vaginal mucus and standing behavior). The onset of estrus was taken as day 0 of the estrous cycle. Only the cows with signs of estrus were chosen for the study. 
Experimental procedure
Experiment 1: LT mRNA expression and production in the bovine CL tissue and localization in the ovary during the estrous cycle and in early pregnancy
The aim of the experiment was to compare whether there are changes in LT production in the bovine CL during the estrous cycle and early pregnancy. Bovine ovaries (nZ20) were obtained from cows divided into two groups: pregnant and cyclic animals. The animals allocated to the pregnant group underwent artificial insemination with semen from the same bull. Ovarian tissue was obtained at a local slaughterhouse (Zaklady Miesne 'Warmia', Biskupiec, Poland) within 20 min of exsanguination and was transported on ice to the laboratory within 40 min. Estimation of the stages of the estrous cycle/pregnancy was monitored as mentioned (the reproductive history of all animals was known) and confirmed by macroscopic observation of the ovaries and uterus after slaughter (Miyamoto et al. 2000) . Pregnancy was confirmed by flushing the uterus for embryo collection (Woclawek-Potocka et al. 2009 ).
Corpora lutea samples were collected on days 2-4 (nZ4), 8-10 (nZ4), and 16-18 (nZ4) of the estrous cycle and days 8-10 (nZ4) and 16-18 (nZ4) of pregnancy. The days of the estrous cycle for evaluation of CL functionality were additionally confirmed by measurement of P 4 concentration in the peripheral blood. Pregnancy was confirmed as described previously (Woclawek-Potocka et al. 2009 ).
mRNA expression was quantitatively measured by real-time RT-PCR for 5-LO and LTB 4 and LTC 4 receptors (BLT and CYSLT respectively) as described previously (Korzekwa et al. 2010a ). Concentrations of P 4 (control of CL stage, data not shown), LTB 4 , and LTC 4 were measured by enzyme immunoassay (EIA) in the CL tissues after extraction according to Korzekwa et al. (2008a) . Immunohistochemistry was conducted in ovarian tissue for BLT, CYSLT, and 5-LO for observation of tissue compartments where LTs are produced.
Experiment 2: LTB 4 and C 4 concentrations in the blood during the estrous cycle and early pregnancy
The aim of the experiment was to follow and compare the changes in LTs concentration during the estrous cycle and early pregnancy. Peripheral blood samples were collected into tubes with 5 ml EDTA and 1% aspirin solution (pH 7.3) from the jugular vein by syringe with needle on days 0, 2, 8, 10, 15, 16, 17, and 21 of the estrous cycle or pregnancy. Blood plasma was separated by centrifugation (2000 g; 10 min at 4 8C) and stored at K20 8C until P 4 , LTB 4 , and LTC 4 determinations were made (nZ12).
Experiment 3: effects of LT antagonists on P 4 and PG output and CL lifespan in vivo LT antagonists were used to test the hypothesis that LTs differentially affect the CL (nZ52) function and lifespan during the estrous cycle and early pregnancy.
Preliminary study: establishing the effective dose of LTB 4 and LTC 4 antagonists. On day 15 of the subsequent estrous cycle, catheters were inserted into the aorta abdominalis through the coccygeal artery of the cows for infusion of either saline (nZ4) or LTB 4 and C 4 antagonists. A second catheter was inserted into the jugular vein for frequent collection of blood samples (Skarzynski et al. 2003a) .
The LT antagonists were infused into the aorta abdominalis on day 16 of the estrous cycle: azelastine (an antagonist of LTC 4 ; azelastine hydrochloride, LKT-A9818-M100; Alexis Biochemicals, Lausen, Switzerland) and dapsone (an antagonist of LTB 4 ; 4,4 0 -diaminodiphenyl sulfone, LKT-ALX-270-090; Alexis Biochemicals) each in three doses: 10, 100, and 250 mg (nZ4 for each dose of LT antagonist) in 20 ml of saline. Peripheral blood samples were collected from the jugular vein before and for 24 h after treatment (18 times, beginning 2 h before the infusions as follows: K2, K1, K0.5, 0, 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 14, 16, 18, 21, and 24 h) . After day 16 of the estrous cycle, blood was collected once daily until day 22 (nZ28). The concentrations of P 4 and PGs (PGE 2 and PGFM; data not shown) in plasma samples were measured. Standing behavior was checked every 12 h after treatment to confirm the onset of estrus.
Effects of LT antagonists on P 4 and PG secretion and CL lifespan during the estrous cycle and early pregnancy
To determine the effects of LT antagonists on CL lifespan and P 4 levels during pregnancy, peripheral blood samples were collected from the jugular vein on days 0, 6, 9, 12, 15, 16, 17, 18 , and 21 of the estrous cycle and days 0, 6, 9, 12, 15, 16, 17, 18, 21, 26, 32 , and 36 of the pregnancy (embryo presence/absence was confirmed on day 32 of pregnancy by USG). The concentrations of P 4 in the plasma samples were measured after centrifugation, as in experiment 2.
To check the effect of blockade of endogenous LT actions on CL function during the estrous cycle and early pregnancy, saline (nZ8) and 250 mg (the dose selected in the preliminary study) dapsone (nZ8) or azelastine (nZ8) were infused into the aorta abdominalis on day 16 of the estrous cycle (nZ24) or pregnancy (nZ24, including 12 animals used from the preliminary study) according to the experimental design from the preliminary study. Peripheral blood samples were collected from the jugular vein before and for 24 h after infusion (18 times, beginning 2 h before the infusions). The concentrations of P 4 , PGE 2 , and PGFM in the plasma samples were measured.
Immunocytochemistry for LTB 4 receptor (BLT), LTC 4 receptor (CYSLT), and 5-LO protein
Cross sections of ovarian tissue samples were fixed in 4% paraformaldehyde in 0.1 M PBS (pHZ7.4), washed in 0.1 M PBS, and cryoprotected in 18% sucrose. Immunostaining was carried out on consecutive sections. Afterwards, 10 mm cryostat sections were stained for specific LT receptors and 5-LO. To block endogenous peroxidase, the sections were treated with hydrogen peroxide in methanol and washed in 0.1 M PBS. Then they were blocked with 10% normal goat serum for 1 h at room temperature, incubated overnight at room temperature with primary rabbit MAB raised against LTB 4 receptor (GTX71293; GeneTex Inc., Irvine, CA, USA), LTC 4 receptor 0 -diaminobenzidine tetrahydrochloride (Sigma Chemical Co. Ltd) in 0.01% hydrogen peroxide in Tris-buffered saline (pHZ7.2) for 2-3 min. Finally, sections were dehydrated and cover-slipped with DPX mounting medium (Park Scientific Ltd, Northampton, UK). To test the specificity of immunohistochemical staining, two types of controls were performed: i) the primary antibody was omitted during the immunostaining procedure; and ii) the primary antibody was substituted with nonspecific IgG. The observations and photographs were made using a light microscope (Nikon FXA, Tokyo, Japan). Classification of ovarian follicles was described according to Rodgers & Irving-Rodgers (2010) .
Total RNA isolation
Total RNA was extracted from ovaries using Trizol reagent according to the manufacturer's instructions. One microgram of each sample of total RNA was reverse transcribed using the SuperScript First-Strand Synthesis System for RT-PCR (11904-018; Invitrogen), as described in the supplier's protocol.
Real-time PCR quantification
Quantitative fluorescence real-time PCR was performed using the Applied Biosystems 7300 System (Applied Biosystems, Foster City, CA, USA) with an SYBR Green PCR master mix (4367659 Power SYBR Green PCR Master Mix; Applied Biosystems) following the manufacturer's instructions. Realtime PCR (25 ml) included 12.5 ml SYBR Green PCR Master Mix, 0.5 mM each of sense and antisense primers, and reversetranscribed cDNA (1 ml cDNA). The primers for 5-LO, BLT, and CYSLT mRNA expression were as detailed in a previous paper (Korzekwa et al. 2010a) . For quantification, standard curves consisting of serial dilutions of the appropriate purified cDNA were plotted. Amplification was preceded by an initial denaturation step (15 min at 95 8C). The PCR programs for each gene were performed as follows: 40 cycles of denaturation (15 s at 95 8C), annealing (30 s at 56 8C), and elongation (60 s at 72 8C). After PCR, melting curves were acquired by stepwise increases at a temperature of 50-95 8C to ensure that a single product was amplified in the reaction. Control reactions in the absence of RT were performed to test for genomic DNA contamination. The specificity of the PCR products for examined genes was confirmed by gel electrophoresis and sequencing. The sequence homology obtained in the experiment was 99%. Dissociation curve analysis was performed after each real-time experiment to confirm the presence of only one product and the absence of the formation of primer dimers. Data were normalized to a calibrator sample using the DDC t method. Samples were run in triplicate, data are shown as the average fold increase, with S.E.M., and were expressed relative to GAPDH as a housekeeping gene, which was expressed at the same levels (C t values) for all examined genes and stages of the estrous cycle and pregnancy.
Extraction of hormones from the CL tissue
LTs were extracted from the CL tissue according to the method described previously (Korzekwa et al. 2008a) .
Hormone determination
Measurements of P 4 and PGE 2 in the CL tissue and plasma were performed using a direct EIA as described previously (Skarzynski et al. 2003a , 2003b , Korzekwa et al. 2004 ). Antiserum to P 4 was donated by Dr S Okrasa (University of Warmia and Mazury, Olsztyn, Poland). The standard curve ranged from 0.39 to 100 ng/ml and the effective dose for 50% inhibition (ED 50 ) of the assay was 4.5 ng/ml. The intra-and interassay coefficients of variation (CV) values were 5.5 and 8.5% respectively. The PGE 2 standard curve ranged from 0.07 to 20 ng/ml and the ID 50 of the assay was 1.25 ng/ml. The intraand interassay CV values averaged 6.9 and 9.7% respectively.
The concentrations of PGFM in the plasma samples were determined with a direct EIA, as described previously (Skarzynski et al. 2003a) . The anti-PGFM serum (WS4468-5) was donated by Dr W J Silvia (University of Kentucky, Lexington, KY, USA). The PGFM standard curve was produced for PGFM concentrations ranging from 32.5 to 8000 pg/ml and the ID 50 of the assay was 315 pg/ml. The intra-and interassay CV values were on average 7.6 and 10.4% respectively.
The concentrations of LTB 4 and C 4 were determined in the culture media using commercially available EIA kits (520211, LTC 4 EIA kit; 520111, LTB 4 EIA kit; Cayman Chemical Co.) according to Korzekwa et al. (2008b) . The LTB 4 standard curve ranged from 1.96 to 1000 pg/ml, and the effective dose for 50% inhibition (ID 50 ) of the assay was 2.5 pg/ml. The intra-and interassay CV values were on average 4.1 and 6.2% respectively. The LTC 4 standard curve ranged from 0.98 to 500 pg/ml and the effective dose for 50% inhibition (ID 50 ) of the assay was 1.85 pg/ml. The intra-and interassay CV values were on average 4.9 and 7.4% respectively.
Statistical analysis
In experiment 1, the determination of every measurement for each group was performed in triplicate. The statistical significance of differences in 5-LO, BLT, and CYSLT expression and the statistical significance of differences in hormone concentrations were analyzed by two-way ANOVA followed by Bonferroni's post hoc test (ANOVA; GraphPAD PRISM Version 4.00, San Diego, CA, USA), if the initial ANOVA was significant (P!0.05). The intensity of the histochemical reactions was estimated by the measurement of optical density (0-450) using Olympus DP SOFT Software (Olympus, Warsaw, Poland). Three slides of each sample were stained and examined under a light microscope (Nikon Microphot FXA).
LT concentration and differences during the estrous cycle and in early pregnancy in experiments 2 and 3, as well the analyses of P 4 , PGE 2 , and PGFM in the plasma samples, collected before, during, and after administration of LT antagonists, were performed using a repeated measures design approach with treatments and the time of sample collection (hours, or days of the cycle or pregnancy) being fixed effects with all interactions included repeated measurement ANOVA tests followed by Bonferroni's multiple comparison test (GraphPAD PRISM Version 5.00). P!0.05 was considered significant.
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